论文部分内容阅读
Introduction: In cirrhosis,the presence of any one or more of jaundice,ascites,portal hypertensive gastrointestinal bleeding,and/or,encephalopathy is considered to be decompensation.Till now the prognosis of decompensated cirrhosis is poor.Medical therapies are difficult to handle and limited in efficacy.The best treatment available now is liver transplantation with the disadvantages such as lack of donor liver,expensive cost and immune rejections.This study is to analyze the effect of umbilical cord blood stem cell transplantation therapy on the patients with decompensated cirrhosis.